EUR 51.64
(-0.57%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 28.55 Billion EUR | -2.24% |
2022 | 29.2 Billion EUR | 13.09% |
2021 | 25.82 Billion EUR | 105.22% |
2020 | 12.58 Billion EUR | 8.04% |
2019 | 11.64 Billion EUR | 5.1% |
2018 | 11.08 Billion EUR | -35.56% |
2017 | 17.19 Billion EUR | -7.25% |
2016 | 18.54 Billion EUR | 17.88% |
2015 | 15.72 Billion EUR | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q1 | 27.65 Billion EUR | -3.15% |
2024 Q3 | 28.34 Billion EUR | 2.45% |
2024 Q2 | 27.66 Billion EUR | 0.05% |
2023 Q3 | 28.31 Billion EUR | 1.26% |
2023 Q2 | 27.96 Billion EUR | -0.17% |
2023 Q1 | 28.01 Billion EUR | -4.07% |
2023 FY | 28.55 Billion EUR | -2.24% |
2023 Q4 | 28.55 Billion EUR | 0.83% |
2022 Q2 | 27.05 Billion EUR | 3.5% |
2022 FY | 29.2 Billion EUR | 13.09% |
2022 Q4 | 29.2 Billion EUR | 5.87% |
2022 Q3 | 27.58 Billion EUR | 1.97% |
2022 Q1 | 26.13 Billion EUR | 1.22% |
2021 Q2 | 22 Billion EUR | 67.19% |
2021 FY | 25.82 Billion EUR | 105.22% |
2021 Q3 | 26.22 Billion EUR | 19.16% |
2021 Q1 | 13.16 Billion EUR | 4.6% |
2021 Q4 | 25.82 Billion EUR | -1.52% |
2020 Q2 | 13.37 Billion EUR | 4.3% |
2020 Q1 | 12.82 Billion EUR | 10.12% |
2020 Q3 | 12.97 Billion EUR | -3.03% |
2020 FY | 12.58 Billion EUR | 8.04% |
2020 Q4 | 12.58 Billion EUR | -3.01% |
2019 Q3 | 11.59 Billion EUR | 6.27% |
2019 FY | 11.64 Billion EUR | 5.1% |
2019 Q4 | 11.64 Billion EUR | 0.42% |
2019 Q2 | 10.91 Billion EUR | -0.42% |
2019 Q1 | 10.96 Billion EUR | -1.1% |
2018 FY | 11.08 Billion EUR | -35.56% |
2018 Q1 | 20.08 Billion EUR | 16.79% |
2018 Q2 | 11.02 Billion EUR | -45.09% |
2018 Q3 | 10.75 Billion EUR | -2.47% |
2018 Q4 | 11.08 Billion EUR | 3.02% |
2017 Q4 | 17.19 Billion EUR | 0.0% |
2017 FY | 17.19 Billion EUR | -7.25% |
2016 FY | 18.54 Billion EUR | 17.88% |
2015 FY | 15.72 Billion EUR | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
Cegedim SA | 629.51 Million EUR | -4435.418% |
Guerbet SA | 646.97 Million EUR | -4313.033% |
Nexus AG | 153.13 Million EUR | -18544.455% |
Bastide Le Confort Médical SA | 566.34 Million EUR | -4941.3% |
Revenio Group Oyj | 37.6 Million EUR | -75833.511% |
Drägerwerk AG & Co. KGaA | 1.84 Billion EUR | -1445.697% |
Sartorius Aktiengesellschaft | 6.99 Billion EUR | -307.994% |
LNA Santé SA | 1.19 Billion EUR | -2281.991% |
Medios AG | 125.94 Million EUR | -22569.239% |
Equasens Société anonyme | 166.41 Million EUR | -17056.094% |
Stratec SE | 246.2 Million EUR | -11496.434% |